Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Integra Lifesciences Holdings (IART) Other Gross PP&E Adjustments (2016 - 2026)

Integra Lifesciences Holdings' Other Gross PP&E Adjustments history spans 16 years, with the latest figure at $740.4 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 13.86% to $740.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $740.4 million, a 13.86% increase, with the full-year FY2025 number at $740.4 million, up 13.86% from a year prior.
  • Other Gross PP&E Adjustments hit $740.4 million in Q4 2025 for Integra Lifesciences Holdings, up from -$165.1 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for IART hit a ceiling of $740.4 million in Q4 2025 and a floor of -$218.1 million in Q1 2025.
  • Historically, Other Gross PP&E Adjustments has averaged $16.6 million across 5 years, with a median of -$166.2 million in 2022.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 55.26% in 2022 and later grew 19.9% in 2024.
  • Tracing IART's Other Gross PP&E Adjustments over 5 years: stood at $528.1 million in 2021, then dropped by 8.62% to $482.6 million in 2022, then rose by 12.39% to $542.3 million in 2023, then increased by 19.9% to $650.3 million in 2024, then increased by 13.86% to $740.4 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for IART at $740.4 million in Q4 2025, -$165.1 million in Q3 2025, and -$190.3 million in Q2 2025.